It's How Medicine Should Be®

Physician Profile


call (888) 352-RUSH for help arranging an appointment

William H. Warren, MD

Patient Feedback
  • Thoracic and Cardiac Surgery
  • Surgery
Board Certification:
  • Thoracic and Cardiac Surgery
Faculty Rank: Professor
Medical or Graduate Education: University of Toronto Faculty of Medicine
Residency: University of Toronto Hospitals - Surgery
  Rush University Medical Center - Pathology
Fellowship: Rush University Medical Center - Cardiovascular-Thoracic Surgery
Clinical Expertise:
  • Bronchoscopy
  • Cancer surgery, lung
  • Chest wall reconstruction
  • Esophagectomy
  • Hyperhidrosis
  • Lung cancer
  • Pectus excavatum
  • Photodynamic therapy
  • Thoracic outlet syndrome
  • Thoracic surgery
  • Tracheal surgery
  • Tracheobronchial stents
  • Video-assisted thoracoscopic surgery (VATS)
Research Interests:
  • Tumor biology
  • Tracheobronchial stents
  • Esophageal stents
  • Preoperative chemotherapy and radiation therapy
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to Listings go back five years.

  1. Circulating Angiogenesis Biomarkers Are Associated With Disease Progression in Lung Adenocarcinoma.
    Daly S, Kubasiak JC, Rinewalt D, Pithadia R, Basu S, Fhied C, Lobato GC, Seder CW, Hong E, Warren WH, Chmielewski G, Liptay MJ, Bonomi P, Borgia JA
    Ann. Thorac. Surg.
    2014 Oct 6
  2. Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection.
    Garg S, Gielda BT, Turian JV, Liptay M, Warren WH, Bonomi P, Sher DJ
    Pract Radiat Oncol
    2013 Oct-Dec
  3. Anterior mediastinal mass secondary to histoplasmosis.
    Shersher DD, Hong E, Breard J, Warren WH, Liptay MJ.
    Ann Thorac Surg. 2012
    2012 Jan
    93(1):e9-10. doi: 10.1016/j.athoracsur.2011.07.093.
  4. Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Sher DJ, Gielda BT, Liptay MJ, Warren WH, Batus M, Fidler MJ, Garg S, Bonomi P.
    Clin Lung Cancer. 2012
    2012 Dec 20. doi:pii: S1525-7304(12)00263-X. 10.1016/j.cllc.2012.10.009. [Epub ahead of print]
  5. Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
    Gielda BT, Mehta P, Khan A, Marsh JC, Zusag TW, Warren WH, Fidler MJ, Abrams RA, Bonomi P, Liptay M, Faber LP.
    Int J Radiat Oncol Biol Phys. 2011
    2011 Nov 15
    81(4):985-91. doi: 10.1016/j.ijrobp.2010.06.059. Epub 2010 Oct 6.
  6. Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer.
    Shersher DD, Vercillo MS, Fhied C, Basu S, Rouhi O, Mahon B, Coon JS, Warren WH, Faber LP, Hong E, Bonomi P, Liptay MJ, Borgia JA.
    Ann Thorac Surg. 2011
    2011 Nov
    92(5):1805-11; discussion 1811. doi: 10.1016/j.athoracsur.2011.06.058. Epub 2011 Sep 25.
  7. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
    Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, Warren WH, Fidler MJ, Batus M, Abrams RA, Bonomi P.
    J Thorac Oncol. 2011
    2011 Jun
    6(6):1079-86. doi: 10.1097/JTO.0b013e3182199a7c.
  8. Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
    Kim AW, Liptay MJ, Bonomi P, Warren WH, Basu S, Farlow EC, Faber LP.
    Ann Thorac Surg. 2011
    2011 Jul
    92(1):233-41; discussion 241-3. doi: 10.1016/j.athoracsur.2011.03.001. Epub 2011 May 28.
  9. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer.
    Kim AW, Batus M, Myint R, Fidler MJ, Basu S, Bonomi P, Faber LP, Wightman SC, Warren WH, McIntire M, Arvanitis LD, Gattuso P, Xu X, Liptay MJ.
    Lung Cancer. 2011
    2011 Feb
    71(2):186-90. doi: 10.1016/j.lungcan.2010.05.006. Epub 2010 Jun 8.
  10. Adenocarcinoma in a 40-year-old colonic interposition treated with Ivor Lewis esophagectomy and esophagogastric anastomosis.
    Shersher DD, Hong E, Warren W, Penfield Faber L, Liptay MJ.
    Ann Thorac Surg. 2011
    2011 Dec
    92(6):e113-4. doi: 10.1016/j.athoracsur.2011.06.025.
  11. A multi-analyte serum test for the detection of non-small cell lung cancer
    Farlow EC, Vercillo MS, Coon JS, Basu S, Kim AW, Faber LP, Warren WH, Bonomi P, Liptay MJ, Borgia JA
    Br J Cancer
    2010 Oct 12
  12. Bilobectomy for non-small cell lung cancer: a search for clinical factors that may affect perioperative morbidity and long-term survival.
    Kim AW, Faber LP, Warren WH, Shah ND, Basu S, Liptay MJ.
    J Thorac Cardiovasc Surg. 2010
    2010 Mar
    139(3):606-11. doi: 10.1016/j.jtcvs.2009.05.044. Epub 2009 Aug 25.
  13. Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy.
    Hollings DD, Higgins RS, Faber LP, Warren WH, Liptay MJ, Basu S, Kim AW.
    Am J Surg. 2010
    2010 Apr
    199(4):558-61. doi: 10.1016/j.amjsurg.2009.11.006.
  14. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S, Kim AW, Warren WH, Liptay MJ, Miller C, Basu S, Faber LP.
    Ann Thorac Surg. 2009
    2009 Sep
    88(3):945-50; discussion 950-1. doi: 10.1016/j.athoracsur.2009.05.084.
  15. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does side really matter?
    Kim AW, Faber LP, Warren WH, Basu S, Wightman SC, Weber JA, Bonomi P, Liptay MJ.
    Ann Thorac Surg. 2009
    2009 Sep
    88(3):937-43; discussion 944. doi: 10.1016/j.athoracsur.2009.04.102.
  16. An unusual case of Aspergillus fibrosing mediastinitis.
    Wightman SC, Kim AW, Proia LA, Faber LP, Gattuso P, Warren WH, Liptay MJ.
    Ann Thorac Surg. 2009
    2009 Oct
    88(4):1352-4. doi: 10.1016/j.athoracsur.2009.02.087.
  17. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.
    Borgia JA, Basu S, Faber LP, Kim AW, Coon JS, Kaiser-Walters KA, Fhied C, Thomas S, Rouhi O, Warren WH, Bonomi P, Liptay MJ.
    J Thorac Oncol. 2009
    2009 Mar
    4(3):338-47. doi: 10.1097/JTO.0b013e3181982abf.
  18. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer.
    Liptay MJ, Basu S, Hoaglin MC, Freedman N, Faber LP, Warren WH, Hammoud ZT, Kim AW.
    J Surg Oncol. 2009
    2009 Dec 15
    100(8):703-7. doi: 10.1002/jso.21407.
  19. Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies.
    Kim AW, Liptay MJ, Saclarides TJ, Warren WH.
    Interact Cardiovasc Thorac Surg. 2009
    2009 Aug
    9(2):379-81. doi: 10.1510/icvts.2009.207555. Epub 2009 May 8.
  20. Repeat pulmonary resection for metachronous colorectal carcinoma is beneficial.
    Kim AW, Faber LP, Warren WH, Saclarides TJ, Carhill AA, Basu S, Choh MS, Liptay MJ.
    Surgery. 2008
    2008 Oct
    144(4):712-7; discussion 717-8. doi: 10.1016/j.surg.2008.07.007. Epub 2008 Aug 29.
  21. Management of malignant pleural effusions using the Pleur(x) catheter.
    Warren WH, Kalimi R, Khodadadian LM, Kim AW.
    Ann Thorac Surg. 2008
    2008 Mar
    85(3):1049-55. doi: 10.1016/j.athoracsur.2007.11.039.
  22. Utility of silicone esophageal bypass stents in the management of delayed complex esophageal disruptions.
    Kim AW, Liptay MJ, Snow N, Donahue P, Warren WH.
    Ann Thorac Surg. 2008
    2008 Jun
    85(6):1962-7; discussion 1967. doi: 10.1016/j.athoracsur.2008.02.043.
  23. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion
    Warren WH, Kim AW, Liptay MJ
    Eur J Cardiothorac Surg
    2008 Jan
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript
Patient feedback information is available for physicians employed by Rush University Medical Center who have received 30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Number of Patient Surveys
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.